SVIP and glioblastoma: In vivo bioluminescence imaging was used to trace tumor progression, and xenografts with SVIP expressing GBM cells displayed a significant suppression in tumor growth (Fig. 6A–C, Supplementary Fig. 4A), and SVIP overexpression resulted in higher survival rate and less weight loss of mice (Fig. 6D, E).